Author: Kryptonews

The Alpenglow hard fork is set to make the Solana network 100x faster, adding fresh fundamental weight to bullish Solana price predictions.The upgrade is an overhaul of the altcoin’s consensus mechanism, targeting sub-second finality by allowing validators to aggregate votes off-chain before submitting final confirmations. Solana is preparing a major consensus upgrade called Alpenglow, targeting sub-second finality.Alpenglow replaces Tower BFT + PoH with two new components:• Votor (vote aggregation)• Rotor (stake-weighted block propagation)Finality latency could drop from 12.8s → 100–150ms.… pic.twitter.com/8llTYRY7qa— VAYLA (@vaylamanager) January 5, 2026 Under this model, blocks can finalize in just one to two confirmation rounds, cutting…

Countless artists have immigrated from countries around the world to the U.S., enriching the American cultural landscape immeasurably. But the process of applying for an O-1B visa, for those with extraordinary ability in sciences, arts, education, business, athletics, or the motion picture/television industry, is a notoriously difficult and expensive process. Lately, some applicants for these visas are able to make a convincing case to the US Citizenship and Immigration Services—those who can increasingly offer concrete online metrics of achievement, including social media influencers and even OnlyFans models, immigration lawyers tell the Financial Times. Related Articles To acquire an O-1B in…

The organizers behind nonfungible token (NFT) and real-world asset (RWA) conferences in Paris have cancelled the events with a month’s notice, citing market forces.In a Monday post, the event’s X account said NFT Paris and RWA Paris, initially set for February, would not be happening as scheduled in 2026. Although the organizers did not explicitly say events would not take place in the future, the message to attendees signaled that they are “clos[ing] this chapter” on conferences.“The market collapse hit us hard,” reads the post. “Despite drastic cost cuts and months of trying to make it work, we couldn’t pull…

The wider crypto space is putting pressure on major names, and recent price action shows clear stress across several charts. Polkadot is holding near $2.06, but analysts continue to warn that a break in support could drag it closer to $1.75. At the same time, Dogecoin remains locked in a tight zone, failing to attract strong buying interest as momentum fades. In contrast, BlockDAG (BDAG) is following a very different path. Its presale has already collected over $441 million and is now approaching its January 26 ending date. With more than 312,000 holders already involved and only a limited number…

Key Highlights The global accounting firm PwC is aggressively expanding into the digital asset sector, moving from its previous anti stance to offer comprehensive services like auditing tokenized assets and compliance consulting. This revelation comes after major U.S. policy changes, including the passage of the GENIUS Act in July 2025 One of the major reasons for PwC’s expansion is the impressive growth of asset tokenization While the digital asset sector is gradually getting regulatory clarity, the global accounting firm PwC is rapidly expanding its business into the digital asset sector.  According to the latest report, the company is now expanding…

The organizers behind nonfungible token (NFT) and real-world asset (RWA) conferences in Paris have cancelled the events with a month’s notice, citing market forces.In a Monday post, the event’s X account said NFT Paris and RWA Paris, initially set for February, would not be happening as scheduled in 2026. Although the organizers did not explicitly say events would not take place in the future, the message to attendees signaled that they are “clos[ing] this chapter” on conferences.“The market collapse hit us hard,” reads the post. “Despite drastic cost cuts and months of trying to make it work, we couldn’t pull…

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure The first week of the year has not been unkind to the market, with Ethereum (ETH) entering 2026 with a mixed narrative that reflects both progress and restraint. On one hand, the network is pushing through long-standing technical limits and seeing broader real-world usage. On the other hand, market data indicate continued selling pressure, which has kept price action subdued. Together, these trends suggest Ethereum is less in decline than in transition, balancing structural growth against a cautious market environment. ETH’s price trends slightly to the upside…

Rongchai Wang Jan 05, 2026 14:35 AAVE price prediction shows bullish momentum building with technical indicators pointing to $185-195 targets as Aave breaks above key resistance levels. The cryptocurrency market is closely watching Aave as technical indicators suggest a potential breakout from current consolidation levels. With AAVE trading at $165.43, multiple signals are aligning for a strategic move higher, making this AAVE price prediction particularly compelling for traders seeking medium-term opportunities. AAVE Price Prediction Summary • AAVE short-term target (1 week): $177-180 (+7-9%) • Aave medium-term forecast (1 month): $185-195 range (+12-18%) •…

Bitcoin BTC$94,115.86 rose to its highest level since mid-November, gaining more than 3% to $94,400 during Monday’s trading session, the largest percentage advance in more than a month.The rally, which brought the asset closer to $95,000 — seen by some analysts as a key level to gain further momentum — was led, though, by XRP$2.3108. After breaking key resistance overnight, XRP added to its move during the U.S. trading day, rising 9% to just shy of $2.32, also the strongest since mid-November.Crypto-related stocks — many of which saw unrelenting selling late in 2025 — were sharply higher across the board.Coinbase (COIN),…

In brief Novo Nordisk rolled out an oral version of Wegovy in the U.S., marking the first pill-based GLP-1 approved specifically for weight loss. GLP-1 drugs from Novo Nordisk and Eli Lilly have surged in popularity, though injections, side effects, and cost have remained barriers for some patients. The pill builds on years of work to deliver an oral-GLP-1 drug that could broaden access as demand for obesity treatments continues to grow. Novo Nordisk’s long-anticipated weight-loss pill finally reached U.S. pharmacies this week, opening a new front in the GLP-1 drug boom fueled by the popular drug.On Monday, the company…